v3.22.4
Revenue Recognition - Summary of Disaggregation of Revenue by Disease State (Detail) - USD ($)
$ in Thousands
3 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Segment Reporting Information [Line Items]    
Revenue $ 56,902 $ 88,341
Revenue, % change (36.00%)  
Diagnostics [Member]    
Segment Reporting Information [Line Items]    
Revenue $ 39,366 33,204
Revenue, % change 19.00%  
Diagnostics [Member] | Gastrointestinal Assays [Member]    
Segment Reporting Information [Line Items]    
Revenue $ 21,273 21,619
Revenue, % change (2.00%)  
Diagnostics [Member] | Respiratory Illness Assays [Member]    
Segment Reporting Information [Line Items]    
Revenue $ 6,714 6,380
Revenue, % change 5.00%  
Diagnostics [Member] | Blood Chemistry Assays [Member]    
Segment Reporting Information [Line Items]    
Revenue $ 4,620 78
Revenue, % change 5823.00%  
Diagnostics [Member] | Other [Member]    
Segment Reporting Information [Line Items]    
Revenue $ 6,759 $ 5,127
Revenue, % change 32.00%